Citigroup

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-12
Total Holdings
8,340
Total Value
44847690535
Accession Number
0000831001-25-000103
Form Type
13F-HR
Manager Name
Citigroup
Data Enrichment
86% identified
7,168 identified1,172 unidentified

Holdings

8,340 positions • $44.8B total value
Manager:
Search and click to pin securities to the top
Page 232 of 239
92189F700
Shares:3
Value:$204
% of Portfolio:0.0% ($204/$44.8B)
BELITE BIO, INC
Shares:3
Value:$199
% of Portfolio:0.0% ($199/$44.8B)
72201R817
Shares:2
Value:$194
% of Portfolio:0.0% ($194/$44.8B)
91829F104
Shares:24
Value:$180
% of Portfolio:0.0% ($180/$44.8B)
G28687104
Shares:2
Value:$177
% of Portfolio:0.0% ($177/$44.8B)
56608A105
Shares:9
Value:$176
% of Portfolio:0.0% ($176/$44.8B)
GALECTIN THERAPEUTICS INC
Shares:141
Value:$172
% of Portfolio:0.0% ($172/$44.8B)
60938K114
Shares:650
Value:$172
% of Portfolio:0.0% ($172/$44.8B)
abrdn Total Dynamic Dividend Fund
Shares:20
Value:$168
% of Portfolio:0.0% ($168/$44.8B)
Offerpad Solutions Inc.
Shares:101
Value:$168
% of Portfolio:0.0% ($168/$44.8B)
Baozun Inc.
Shares:61
Value:$167
% of Portfolio:0.0% ($167/$44.8B)
MINISO Group Holding Ltd
Shares:9
Value:$166
% of Portfolio:0.0% ($166/$44.8B)
68236V302
Shares:163
Value:$160
% of Portfolio:0.0% ($160/$44.8B)
Syra Health Corp
Shares:598
Value:$155
% of Portfolio:0.0% ($155/$44.8B)
301505889
Shares:4
Value:$153
% of Portfolio:0.0% ($153/$44.8B)
Seres Therapeutics, Inc.
Shares:215
Value:$151
% of Portfolio:0.0% ($151/$44.8B)
PLUS THERAPEUTICS, INC.
Shares:146
Value:$139
% of Portfolio:0.0% ($139/$44.8B)
025072802
Shares:2
Value:$139
% of Portfolio:0.0% ($139/$44.8B)
PETMED EXPRESS INC
Shares:32
Value:$134
% of Portfolio:0.0% ($134/$44.8B)
Whitehawk Therapeutics, Inc.
Shares:75
Value:$134
% of Portfolio:0.0% ($134/$44.8B)